Back to results
US 7,452,983 B2Granted
Protein which binds to Akt2
AssigneeAstellas Pharma Inc.
InventorsYuki Endo, Hideki Endoh, Yoshitaka Ueda, Miyuki Kato, Kazunori Inabe
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeAstellas Pharma Inc.
InventorsYuki Endo, Hideki Endoh, Yoshitaka Ueda, Miyuki Kato, Kazunori Inabe
Estimating the term…
A novel polypeptide, a polynucleotide, an expression vector, a cell transfected with the expression vector, a method for screening an insulin resistance improving agent and a carbohydrate metabolism improving agent, and a method for producing a pharmaceutical composition are provided. The polypeptide is useful in screening an insulin resistance improving agent and a carbohydrate metabolism improving agent. When the polypeptide is overexpressed in a fat cell, the activity of Akt2 is reduced. Fat cells express the polypeptide. The polynucleotide encodes the polypeptide. The expression vector includes the polynucleotide. The screening method uses the polypeptide to screen for an insulin resistance improving agent and a carbohydrate metabolism improving agent. The production method uses the substance obtained by the screening method as the active ingredient of the pharmaceutical composition. The pharmaceutical composition is useful for insulin resistance improvement and carbohydrate metabolism improvement.
An isolated polypeptide which comprises the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4 and which binds to Akt-homolog-2 (“Akt2”).
An isolated polypeptide consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4.
An isolated polynucleotide encoding
An expression vector comprising a polynucleotide encoding
An isolated cell transformed with an expression vector comprising a polynucleotide encoding
Dependencies are inferred from the claim text.